Specific changes in faecal microbiota are associated with familial Mediterranean fever
© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ..
OBJECTIVES: Familial Mediterranean fever (FMF) can be complicated by AA amyloidosis (AAA), though it remains unclear why only some patients develop amyloidosis. We examined the gut microbiota composition and inflammatory markers in patients with FMF complicated or not by AAA.
METHODS: We analysed the gut microbiota of 34 patients with FMF without AAA, 7 patients with FMF with AAA, 19 patients with AAA of another origin, and 26 controls using 16S ribosomal RNA gene sequencing with the Illumina MiSeq platform. Associations between bacterial taxa and clinical phenotypes were evaluated using multivariate association with linear models statistical method. Blood levels of interleukin (IL)-1β, IL-6, tumour necrosis factor-α and adipokines were assessed by ELISA; indoleamine 2,3-dioxygenase (IDO) activity was determined by high-performance liquid chromatography.
RESULTS: Compared with healthy subjects, specific changes in faecal microbiota were observed in FMF and AAA groups. Several operational taxonomic units (OTUs) were associated with FMF. Moreover, two OTUs were over-represented in FMF-related AAA compared with FMF without AAA. Additionally, higher adiponectin levels and IDO activity were observed in FMF-related AAA compared with FMF without AAA (p<0.05).
CONCLUSION: The presence of specific changes in faecal microbiota in FMF and in FMF-related AAA suggests that intestinal microorganisms may play a role in the pathogenesis of these diseases. These findings may offer an opportunity to use techniques for gut microbiota manipulation.
| Errataetall: |
CommentIn: Ann Rheum Dis. 2021 Nov;80(11):e176. - PMID 31727626 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2019 |
|---|---|
| Erschienen: |
2019 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:78 |
|---|---|
| Enthalten in: |
Annals of the rheumatic diseases - 78(2019), 10 vom: 02. Okt., Seite 1398-1404 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Deshayes, Samuel [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 30.03.2020 Date Revised 13.11.2021 published: Print-Electronic CommentIn: Ann Rheum Dis. 2021 Nov;80(11):e176. - PMID 31727626 Citation Status MEDLINE |
|---|
| doi: |
10.1136/annrheumdis-2019-215258 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM29989018X |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM29989018X | ||
| 003 | DE-627 | ||
| 005 | 20231225101328.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1136/annrheumdis-2019-215258 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0999.xml |
| 035 | |a (DE-627)NLM29989018X | ||
| 035 | |a (NLM)31377728 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Deshayes, Samuel |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Specific changes in faecal microbiota are associated with familial Mediterranean fever |
| 264 | 1 | |c 2019 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 30.03.2020 | ||
| 500 | |a Date Revised 13.11.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentIn: Ann Rheum Dis. 2021 Nov;80(11):e176. - PMID 31727626 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ. | ||
| 520 | |a OBJECTIVES: Familial Mediterranean fever (FMF) can be complicated by AA amyloidosis (AAA), though it remains unclear why only some patients develop amyloidosis. We examined the gut microbiota composition and inflammatory markers in patients with FMF complicated or not by AAA | ||
| 520 | |a METHODS: We analysed the gut microbiota of 34 patients with FMF without AAA, 7 patients with FMF with AAA, 19 patients with AAA of another origin, and 26 controls using 16S ribosomal RNA gene sequencing with the Illumina MiSeq platform. Associations between bacterial taxa and clinical phenotypes were evaluated using multivariate association with linear models statistical method. Blood levels of interleukin (IL)-1β, IL-6, tumour necrosis factor-α and adipokines were assessed by ELISA; indoleamine 2,3-dioxygenase (IDO) activity was determined by high-performance liquid chromatography | ||
| 520 | |a RESULTS: Compared with healthy subjects, specific changes in faecal microbiota were observed in FMF and AAA groups. Several operational taxonomic units (OTUs) were associated with FMF. Moreover, two OTUs were over-represented in FMF-related AAA compared with FMF without AAA. Additionally, higher adiponectin levels and IDO activity were observed in FMF-related AAA compared with FMF without AAA (p<0.05) | ||
| 520 | |a CONCLUSION: The presence of specific changes in faecal microbiota in FMF and in FMF-related AAA suggests that intestinal microorganisms may play a role in the pathogenesis of these diseases. These findings may offer an opportunity to use techniques for gut microbiota manipulation | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a AA amyloidosis | |
| 650 | 4 | |a adipokines | |
| 650 | 4 | |a familial Mediterranean fever | |
| 650 | 4 | |a indoleamine 2,3-dioxygenase | |
| 650 | 4 | |a microbiota | |
| 650 | 7 | |a ADIPOQ protein, human |2 NLM | |
| 650 | 7 | |a Adiponectin |2 NLM | |
| 650 | 7 | |a Biomarkers |2 NLM | |
| 650 | 7 | |a Cytokines |2 NLM | |
| 650 | 7 | |a Inflammation Mediators |2 NLM | |
| 700 | 1 | |a Fellahi, Soraya |e verfasserin |4 aut | |
| 700 | 1 | |a Bastard, Jean-Philippe |e verfasserin |4 aut | |
| 700 | 1 | |a Launay, Jean-Marie |e verfasserin |4 aut | |
| 700 | 1 | |a Callebert, Jacques |e verfasserin |4 aut | |
| 700 | 1 | |a Fraisse, Thibault |e verfasserin |4 aut | |
| 700 | 1 | |a Buob, David |e verfasserin |4 aut | |
| 700 | 1 | |a Boffa, Jean-Jacques |e verfasserin |4 aut | |
| 700 | 1 | |a Giurgea, Irina |e verfasserin |4 aut | |
| 700 | 1 | |a Dupont, Charlotte |e verfasserin |4 aut | |
| 700 | 1 | |a Jegou, Sarah |e verfasserin |4 aut | |
| 700 | 1 | |a Straube, Marjolène |e verfasserin |4 aut | |
| 700 | 1 | |a Karras, Alexandre |e verfasserin |4 aut | |
| 700 | 1 | |a Aouba, Achille |e verfasserin |4 aut | |
| 700 | 1 | |a Grateau, Gilles |e verfasserin |4 aut | |
| 700 | 1 | |a Sokol, Harry |e verfasserin |4 aut | |
| 700 | 1 | |a Georgin-Lavialle, Sophie |e verfasserin |4 aut | |
| 700 | 0 | |a AA Amyloidosis Study Group |e verfasserin |4 aut | |
| 700 | 0 | |a AA amyloidosis Study Group |e verfasserin |4 aut | |
| 700 | 1 | |a Amselem, Serge |e investigator |4 oth | |
| 700 | 1 | |a Louvrier, Camille |e investigator |4 oth | |
| 700 | 1 | |a Savey, Léa |e investigator |4 oth | |
| 700 | 1 | |a Galland, Joris |e investigator |4 oth | |
| 700 | 1 | |a Hankard, Antoine |e investigator |4 oth | |
| 700 | 1 | |a Cez, Alexandre |e investigator |4 oth | |
| 700 | 1 | |a Michel, Pierre-Antoine |e investigator |4 oth | |
| 700 | 1 | |a Knebelmann, Bertrand |e investigator |4 oth | |
| 700 | 1 | |a Hertig, Alexandre |e investigator |4 oth | |
| 700 | 1 | |a Isnard Bagnis, Corinne |e investigator |4 oth | |
| 700 | 1 | |a Belenfant, Xavier |e investigator |4 oth | |
| 700 | 1 | |a Martin Silva, Nicolas |e investigator |4 oth | |
| 700 | 1 | |a Saadoun, David |e investigator |4 oth | |
| 700 | 1 | |a Legris, Tristan |e investigator |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Annals of the rheumatic diseases |d 1939 |g 78(2019), 10 vom: 02. Okt., Seite 1398-1404 |w (DE-627)NLM000174114 |x 1468-2060 |7 nnns |
| 773 | 1 | 8 | |g volume:78 |g year:2019 |g number:10 |g day:02 |g month:10 |g pages:1398-1404 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1136/annrheumdis-2019-215258 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 78 |j 2019 |e 10 |b 02 |c 10 |h 1398-1404 | ||